This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Bristol-Myers Squibb Compnay. Active years: 2017.
Company Filing History:
Years Active: 2017
Title: The Innovations of Yaofeng Cheng
Introduction
Yaofeng Cheng is a notable inventor based in Plainsboro, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds that serve as inhibitors for specific enzymes. His work is crucial in advancing therapeutic options for various diseases.
Latest Patents
Yaofeng Cheng holds a patent for "Isotopically labeled triazolopyridine 11-beta hydroxysteroid dehydrogenase type I inhibitors." This patent describes novel compounds that act as 11-beta-hydroxysteroid dehydrogenase type I inhibitors. These inhibitors are beneficial in treating, preventing, or slowing the progression of diseases that require such therapy. The compounds are characterized by a specific formula, which includes an isotopically labeled hydroxypropyl moiety.
Career Highlights
Cheng is currently employed at Bristol-Myers Squibb Company, where he continues to innovate and contribute to the pharmaceutical industry. His work focuses on developing new therapeutic agents that can improve patient outcomes.
Collaborations
Some of his notable coworkers include Bach D Tran and Jun Li. Their collaborative efforts enhance the research and development processes within their organization.
Conclusion
Yaofeng Cheng's contributions to the field of pharmaceuticals through his innovative patents and collaborative work at Bristol-Myers Squibb Company highlight his importance as an inventor. His research continues to pave the way for advancements in medical therapies.